Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aviron -- Ignore unavailable to you. Want to Upgrade?

To: ewolf who wrote (387)	9/28/1998 4:58:00 PM
From: John Finley	Respond to of 645

Dang, I was going to sell 1/2 on the news but had a brain hiccup and didn't sell. That'll learn me to do what I planned! It's not as if everyone didn't know what was going to happen. JF

To: ewolf who wrote (387)	9/28/1998 8:52:00 PM
From: Dennis	Respond to of 645

Monday, Sept. 28th IBD Page A2 "GLAXO NOSE SPRAY MAY PREVENT FLU" The experimental nose spray was designed to help ease the misery of flu symptoms, but it also seems to prevent some people from getting sick at all. Glaxo Wellcome said a study shows zanamivir, made under the name Relenza, cuts the risk of flu by 67%. Relenza was tested on 1,107 college students in Michigan and Missouri last year just before an outbreak of influenza A. Overall, 11 of those taking the drug fell ill, as did 34 people without it. Taken from IBD Comments?????????